Aida Pharmaceuticals, Inc. (AIDA)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
At close: Dec 30, 2025
Aida Pharmaceuticals Revenue
Aida Pharmaceuticals had revenue of $11.89M in the quarter ending September 30, 2008, with 61.19% growth. This brings the company's revenue in the last twelve months to $40.51M, up 41.27% year-over-year. In the year 2007, Aida Pharmaceuticals had annual revenue of $29.20M, down -1.48%.
Revenue (ttm)
40.51M
Revenue Growth
+41.27%
P/S Ratio
0.00
Revenue / Employee
90.01K
Employees
450
Market Cap
8.13K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 29.20M | -439.32K | -1.48% |
| Dec 31, 2006 | 29.64M | 5.12M | 20.86% |
| Dec 31, 2005 | 24.53M | 8.88M | 56.77% |
| Dec 31, 2004 | 15.65M | 3.06M | 24.27% |
| Dec 31, 2003 | 12.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| FutureWorld | 251.68K |
| Winston Pharmaceuticals | 1.37M |
| SES Solar | 5.51M |
| Bloomios | 8.23M |
| China Health Industries Holdings | 95.95K |
| CEN Biotech | 1.03M |
| MJ Holdings | -227.93K |
| CuraScientific | 1.05M |